BIO:NYSE
Bio-Rad Laboratories, Inc. Class A Common Stock
$370.04
arrow_downward
-1.98%(-7.46) 1D
Sep 10, 9:50:57 AM GMT-4 · USD
search
All symbols
1D
5D
1M
6M
YTD
1Y
5Y
MAX
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for BIO...
Open
$379.92
High
$382.01
Low
$369.71
Mkt. cap
9.82B
Avg. vol.
251.66K
Volume
8.90K
P/E ratio
44.86
52-wk high
$396.23
52-wk low
$236.73
EPS
$8.25
Beta
1.07
Shares outstanding
21.68M
No. of employees
7K
Open
$379.92
High
$382.01
Low
$369.71
Mkt. cap
9.82B
Avg. vol.
251.66K
Volume
8.90K
P/E ratio
44.86
52-wk high
$396.23
52-wk low
$236.73
EPS
$8.25
Beta
1.07
Shares outstanding
21.68M
No. of employees
7K
News stories
From web sources and news partners
Stock Titan
·
15 hours ago
1,453 stock units vest for Bio-Rad (NYSE: BIO) insider as 551 shares withheld
DirectorsTalk Interviews
·
3 days ago
Bio-Rad Laboratories, Inc. (BIO) Stock Analysis: Navigating Current Market Challenges with Strategic Insights
Profile
Bio-Rad Laboratories, Inc. is an American developer and manufacturer of specialized technological products for the life science research and clinical diagnostics markets. The company was founded in 1952 in Berkeley, California, by husband and wife team David and Alice Schwartz, both graduates of the University of California, Berkeley. Bio-Rad is based in Hercules, California, and has operations worldwide. Wikipedia
About Bio-Rad Laboratories, Inc. Class A Common Stock
CEONorman David Schwartz
Employees7.45K
Founded1952
HeadquartersHercules, California, United States
SectorHealth care
Websitebio-rad.com